Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Zambian Civil Society Organizations, TRIPS and Access to Me
Zambian Civil Society Organizations, TRIPS and Access to Me
by giovanna-bartolotta
Zambia Civil Society Consultation Meeting. 1. st....
Introduction: Historic Background
Introduction: Historic Background
by mackenzie
of Pharmacy . Practice. Dr. Haider Raheem. Tracing...
European Medicines Agency Evaluation of Medicines for Human Use7 Westf
European Medicines Agency Evaluation of Medicines for Human Use7 Westf
by luanne-stotts
(COMMITTEE ABBREVIATION) GUIDELINE ON VIRUS SAFET...
uropean Medicines Agency Evaluation of Medicines for Human Use 7 Wes
uropean Medicines Agency Evaluation of Medicines for Human Use 7 Wes
by alexa-scheidler
Page 2 of 7 EMEA 2005 TABLE OF...
About OMICS Group
About OMICS Group
by calandra-battersby
OMICS Group International is an amalgamatio...
European Medicines Agency Evaluation of Medicines for Human Use7 West
European Medicines Agency Evaluation of Medicines for Human Use7 West
by briana-ranney
GUIDELINE ON THE LIMITS OF GENOTOXIC IMPURITIES ...
uropean Medicines Agency Evaluation of Medicines for Human Use 7 Wes
uropean Medicines Agency Evaluation of Medicines for Human Use 7 Wes
by kittie-lecroy
EMEA/CHMP/BMWP/31329/2005 Page 2/6 EMEA 2006 TAB...
European Medicines Agency Evaluation of Medicines for Human Use7 Westf
European Medicines Agency Evaluation of Medicines for Human Use7 Westf
by sherrill-nordquist
(CHMP) SEALANT/HAEMOSTATIC PRODUCTS (CPMP/BPWG/1...
European Medicines Agency Evaluation of Medicines for Human Use7 West
European Medicines Agency Evaluation of Medicines for Human Use7 West
by debby-jeon
GUIDELINE ON THE LIMITS OF GENOTOXIC IMPURITIES ...
European Medicines Agency Human Medicines Evaluation Unit Westferry Circus Canary Wharf London E HB UK Tel
European Medicines Agency Human Medicines Evaluation Unit Westferry Circus Canary Wharf London E HB UK Tel
by liane-varnes
4420 74 18 84 00 Fax 4420 74 18 84 09 Email maile...
1   March 2012 U.S. Department of Health and Human Services
1   March 2012 U.S. Department of Health and Human Services
by lindy-dunigan
Health Resources and Services . Administration. O...
About OMICS Group OMICS Group International is an amalgamation of 
About OMICS Group OMICS Group International is an amalgamation of 
by natalia-silvester
Open Access publications.  and worldwide interna...
About OMICS Group OMICS Group International is an amalgamation of 
About OMICS Group OMICS Group International is an amalgamation of 
by aaron
Open Access publications.  and worldwide interna...
uropean Medicines Agency Evaluation of Medicines for Human Use 7 Wes
uropean Medicines Agency Evaluation of Medicines for Human Use 7 Wes
by amelia
Page 2 of 7 EMEA 2005 TABLE OF CONTENTS 1 INTRODU...
European Medicines Agency Evaluation of Medicines for Human Use7 West
European Medicines Agency Evaluation of Medicines for Human Use7 West
by udeline
COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (...
European Medicines Agency Evaluation of Medicines for Human Use Westferry Circus Canary Wharf London E HB UK Tel
European Medicines Agency Evaluation of Medicines for Human Use Westferry Circus Canary Wharf London E HB UK Tel
by briana-ranney
4420 74 18 84 00 Fax 4420 74 18 85 45 Email maile...
Environmental Side Effects of Medication
Environmental Side Effects of Medication
by anastasia
Alistair B A Boxall. Environment Department. Locat...
5 August 2014EMA/305821/2006Rev.Human Medicines EvaluationDivisionheck
5 August 2014EMA/305821/2006Rev.Human Medicines EvaluationDivisionheck
by phoebe-click
, which reflect the items which must appear on the...
Use of Non consented Human Medicines Importation and S
Use of Non consented Human Medicines Importation and S
by kittie-lecroy
Use of non consented human medicines The Ministr...
September EMA Inspections and Human Medicines Pharmacovigilance D ivision Questions answers on signal management This document addresses a number of questions which stakeholders in particular marke
September EMA Inspections and Human Medicines Pharmacovigilance D ivision Questions answers on signal management This document addresses a number of questions which stakeholders in particular marke
by alida-meadow
If you have a question on signal managem ent that...
September EMA Rev
September EMA Rev
by ellena-manuel
15 Inspections Human Medicines Pharmacovigilance ...
JuneEMEA/5542/02/Rev Human Medicines Evaluation DivisionThe linguistic
JuneEMEA/5542/02/Rev Human Medicines Evaluation DivisionThe linguistic
by danika-pritchard
( At submission and during assessment, only the E...
IP & Access to Medicines
IP & Access to Medicines
by debby-jeon
Round Table, EPIP 2017, Bordeaux. Chirantan Chatt...
The key principles of pharmacology
The key principles of pharmacology
by danika-pritchard
Pharmacodynamics. is the study of . the effect o...
1 TRIPS and Public Health: Implications for the Pharmaceutical Sector in Africa
1 TRIPS and Public Health: Implications for the Pharmaceutical Sector in Africa
by lindy-dunigan
Update on Pharmaceutical . Manufacturing Plan for...
Scanning packs – what to look for Implementing the EU Falsified Medicines Directive in the UK
Scanning packs – what to look for Implementing the EU Falsified Medicines Directive in the UK
by alida-meadow
Scanning packs – what to look for Implementing ...
Human Medicines DivisionAbbreviation of names of days on calendarised
Human Medicines DivisionAbbreviation of names of days on calendarised
by sophia2
1 January 2021EMA/188814/2012rev1MondayTuesdayWedn...
Non-clinical d evelopment
Non-clinical d evelopment
by jade
Once a lead molecule (candidate compound) is ident...
TIF.ACCESS Programme: Guidance and Best Practices for Patient Associations
TIF.ACCESS Programme: Guidance and Best Practices for Patient Associations
by rodriguez
Eleni Antoniou. Senior Policy Officer. Thalassaemi...